- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
GCNT2 Antibody (Center)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP18452c | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP18452c-ev20 | 20 ug 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
GCNT2 Antibody (Center) - Product info | |
| Application | WB
|
| Primary Accession | Q8N0V5 |
| Other Accession | NP_663624.1 |
| Reactivity | Human |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 45873 Da |
GCNT2 Antibody (Center) - Additional info | |
| Gene ID 2651 | |
| Other Names GCNT2; GCNT5; II; NACGT1; N-acetyllactosaminide beta-1, 6-N-acetylglucosaminyl-transferase, isoform A; I-branching enzyme; IGNT | |
| Target/Specificity This GCNT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 212-240 amino acids from the Central region of human GCNT2. | |
| Dilution WB~~1:100~500WB~~1:1000 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions GCNT2 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures. | |
GCNT2 Antibody (Center) - Protein Information | |
| Name GCNT2 | |
| Synonyms GCNT5, II, NACGT1 | |
| Function Branching enzyme that converts linear into branched poly-N-acetyllactosaminoglycans. Introduces the blood group I antigen during embryonic development. It is closely associated with the development and maturation of erythroid cells. The expression of the blood group I antigen in erythrocytes is determined by isoform C | |
| Cellular Location Golgi apparatus membrane; Single-pass type II membrane protein (By similarity) | |
| Tissue Location Isoform B is expressed in lens epithelium cells. Isoform C is expressed in reticulocytes | |
GCNT2 Antibody (Center) - Related products
AP10215b: GCNT2 Antibody (C-term)
AP18452c: GCNT2 Antibody (Center)
DC14682: Human GCNT2 cDNA Clone
GCNT2 Antibody (Center) - Application data
-
GCNT2 Antibody (Center) (Cat. #AP18452c) western blot analysis in A549 cell line lysates (35ug/lane).This demonstrates the GCNT2 Antibody detected the GCNT2 protein (arrow).
GCNT2 Antibody (Center) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene encodes the enzyme responsible for formation of the blood group I antigen. The i and I antigens are distinguished by linear and branched poly-N-acetyllactosaminoglycans, respectively. The encoded protein is the I-branching enzyme, a beta-1,6-N-acetylglucosaminyltransferase responsible for the conversion of fetal i antigen to adult I antigen in erythrocytes during embryonic development. Mutations in this gene have been associated with adult i blood group phenotype. Alternatively spliced transcript variants encoding different isoforms have been described.
REFERENCES
Twu, Y.C., et al. Blood 110(13):4526-4534(2007) Wang, L., et al. Biochem. Biophys. Res. Commun. 331(4):958-963(2005) Pras, E., et al. Invest. Ophthalmol. Vis. Sci. 45(6):1940-1945(2004) Inaba, N., et al. Blood 101(7):2870-2876(2003) Yu, L.C., et al. Blood 101(6):2081-2088(2003)